Pediatrix Medical Group, Inc. (MD) stock
MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/305% above fair value
$31.89+0.59 (+1.88%)
Close on Nov 16, 2026Market cap $2.49BP/E 17.3Yield –
Pediatrix Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Pediatrix Medical's operating cash flow for the twelve months ending Sep 30, 2026 was $226.89M, down 21.8% year over year. For fiscal 2025 it was $271.09M, up 31.2% from the year before. Over ten years it grew -3.0% a year on average. The highest annual figure on record is $511.38M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $271.09M | +31.2% |
| FY2024 | Dec 31, 2024 | $206.57M | +50.4% |
| FY2023 | Dec 31, 2023 | $137.33M | -17.7% |
| FY2022 | Dec 31, 2022 | $166.94M | +117.5% |
| FY2021 | Dec 31, 2021 | $76.74M | -62.5% |
| FY2020 | Dec 31, 2020 | $204.62M | -42.8% |
| FY2019 | Dec 31, 2019 | $357.71M | +14.0% |
| FY2018 | Dec 31, 2018 | $313.71M | -38.7% |
| FY2017 | Dec 31, 2017 | $511.38M | +15.2% |
| FY2016 | Dec 31, 2016 | $443.78M | +20.4% |
| FY2015 | Dec 31, 2015 | $368.70M | -12.8% |
| FY2014 | Dec 31, 2014 | $422.64M | +4.3% |
| FY2013 | Dec 31, 2013 | $405.40M | +24.8% |
| FY2012 | Dec 31, 2012 | $324.91M | +20.0% |
| FY2011 | Dec 31, 2011 | $270.67M | +12.5% |
| FY2010 | Dec 31, 2010 | $240.56M | -0.3% |
| FY2009 | Dec 31, 2009 | $241.37M | +33.1% |
| FY2008 | Dec 31, 2008 | $181.39M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $117.31M | -14.6% |
| Q2 FY2026 | Jun 30, 2026 | $125.32M | -8.6% |
| Q1 FY2026 | Mar 31, 2026 | -$129.85M | – |
| Q4 FY2025 | Dec 31, 2025 | $114.10M | -14.2% |
| Q3 FY2025 | Sep 30, 2025 | $137.29M | +49.5% |
| Q2 FY2025 | Jun 30, 2025 | $137.17M | +28.3% |
| Q1 FY2025 | Mar 31, 2025 | -$117.46M | – |
| Q4 FY2024 | Dec 31, 2024 | $133.01M | +92.1% |
| Q3 FY2024 | Sep 30, 2024 | $91.84M | +14.9% |
| Q2 FY2024 | Jun 30, 2024 | $106.95M | +20.1% |
| Q1 FY2024 | Mar 31, 2024 | -$125.23M | – |
| Q4 FY2023 | Dec 31, 2023 | $69.25M | -29.8% |
| Q3 FY2023 | Sep 30, 2023 | $79.94M | -4.1% |
| Q2 FY2023 | Jun 30, 2023 | $89.05M | +8.1% |
| Q1 FY2023 | Mar 31, 2023 | -$100.92M | – |
| Q4 FY2022 | Dec 31, 2022 | $98.69M | +123.1% |
| Q3 FY2022 | Sep 30, 2022 | $83.33M | +36.4% |
| Q2 FY2022 | Jun 30, 2022 | $82.41M | +53.8% |
| Q1 FY2022 | Mar 31, 2022 | -$97.48M | – |
| Q4 FY2021 | Dec 31, 2021 | $44.24M | – |
| Q3 FY2021 | Sep 30, 2021 | $61.10M | -64.0% |
| Q2 FY2021 | Jun 30, 2021 | $53.59M | -71.6% |
| Q1 FY2021 | Mar 31, 2021 | -$82.19M | – |
| Q4 FY2020 | Dec 31, 2020 | -$11.87M | -108.8% |
| Q3 FY2020 | Sep 30, 2020 | $169.94M | +6.7% |
| Q2 FY2020 | Jun 30, 2020 | $188.44M | +57.0% |
| Q1 FY2020 | Mar 31, 2020 | -$141.88M | – |
| Q4 FY2019 | Dec 31, 2019 | $135.30M | -10.6% |
| Q3 FY2019 | Sep 30, 2019 | $159.20M | +13.1% |
| Q2 FY2019 | Jun 30, 2019 | $120.03M | -11.2% |
| Q1 FY2019 | Mar 31, 2019 | -$56.82M | – |
| Q4 FY2018 | Dec 31, 2018 | $151.38M | -22.6% |
| Q3 FY2018 | Sep 30, 2018 | $140.73M | -29.6% |
| Q2 FY2018 | Jun 30, 2018 | $135.24M | -1.7% |
| Q1 FY2018 | Mar 31, 2018 | -$113.63M | – |
| Q4 FY2017 | Dec 31, 2017 | $195.64M | +49.4% |
| Q3 FY2017 | Sep 30, 2017 | $199.93M | – |
| Q2 FY2017 | Jun 30, 2017 | $137.58M | – |
| Q1 FY2017 | Mar 31, 2017 | -$21.76M | – |
| Q4 FY2016 | Dec 31, 2016 | $130.95M | – |
See a number that looks wrong?